Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes.
Langer
S Z
SZ
Department of Biology, Synthélabo Recherche (L.E.R.S.), Paris, France.
Arbilla
S
S
Benavides
J
J
Scatton
B
B
D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D001569:Benzodiazepines; D001667:Binding, Competitive; D018118:Chloride Channels; D002712:Chlorides; D006993:Hypnotics and Sedatives / Q000378:metabolism*; D007093:Imidazoles / Q000378:metabolism*; D008565:Membrane Proteins / Q000187:drug effects; D015394:Molecular Structure; D011725:Pyridines / Q000378:metabolism*; D011963:Receptors, GABA-A / Q000378:metabolism*; D000077334:Zolpidem
D014151:Anti-Anxiety Agents; D018118:Chloride Channels; D002712:Chlorides; D006993:Hypnotics and Sedatives; D007093:Imidazoles; D008565:Membrane Proteins; D011725:Pyridines; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D000077334:Zolpidem; C052036:alpidem